Dupilumab Consistently Improves Rhinoconjunctivitis-Specific Health-Related Quality of Life in Patients With Uncontrolled, Moderate-To-Severe Asthma and Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.307
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-To-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Dupilumab Suppresses Inflammatory Biomarkers in Asthma Patients With or Without Allergic Rhinitis: Post Hoc Analysis of the LIBERTY ASTHMA QUEST Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Herbal Medicine Cordyceps Sinensis Improves Health-Related Quality of Life in Moderate-To-Severe Asthma

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2016English

Dupilumab Efficacy and Safety in Moderate-To-Severe Uncontrolled AsthmaEfficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

Pediatrics
Child HealthPediatricsPerinatology
2018English

Pss43 - Dupilumab Improves Absenteeism in Moderate-To-Severe Atopic Dermatitis Patients Compared With Placebo in Phase 3 Liberty Ad Solo Studies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Analysis of the Quality of Life of Patients With Asthma and Allergic Rhinitis After Immunotherapy

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2016English

Dupilumab Treatment Improves Quality of Life in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results From a Randomized, Placebo-Controlled Clinical Trial

British Journal of Dermatology
DermatologyMedicine
2018English

Health Related Quality of Life and Health Care Utilization in Primary Care Patients With Moderate/Persistent Severity Asthma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

P68 Asthma Symptom Improvements With Benralizumab Are Associated With Improvements in Activity Functions and Quality of Life for Patients With Severe, Uncontrolled Asthma: Results of Pooled Phase Iii Benralizumab Studies

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy